Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

As consumers who use GLP-1 drugs seek lean, protein-rich foods, the demand for ground turkey has been increasing.

That's a potential steal. The average stock in the Health Care Select Sector SPDR Fund trades at a multiple of just under 18 ...

Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.

Declining sugar consumption among people taking GLP-1 drugs to combat diabetes and obesity and the impact of President’s ...

Supergut is setting sights on bold retail expansion with the help of fresh capital and new executive leadership with a track ...

While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...

In recent years, the landscape of diabetes and weight management has been significantly altered by the rise of glucagon-like peptide-1 (GLP-1) receptor agonists. These medications, initially developed ...

CagriSema from Novo Nordisk activates both GLP-1 and amylin receptors. It is currently the subject of several clinical trials ...

Gut health brand Supergut has secured new capital from Full Frame Growth Partners, and brought in former president of Vital Proteins as CEO.

Recipe photos: Morgan Hunt Glaze and Jen Causey. EatingWell design.